SVOBODOVÁ, Markéta, Martina RAUDENSKÁ, Jaromír GUMULEC, Jan BALVAN, Michaela FOJTŮ, Monika KRATOCHVÍLOVÁ, Hana POLANSKÁ, Zuzana HORÁKOVÁ, Rom KOSTŘICA, Petr BABULA, Z. HEGER and Michal MASAŘÍK. Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations. Oncotarget. Albany: Impact Journals, 2017, vol. 8, No 39, p. 66254-66269. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.19914.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations
Authors SVOBODOVÁ, Markéta (203 Czech Republic, belonging to the institution), Martina RAUDENSKÁ (203 Czech Republic, belonging to the institution), Jaromír GUMULEC (203 Czech Republic, belonging to the institution), Jan BALVAN (203 Czech Republic, belonging to the institution), Michaela FOJTŮ (203 Czech Republic, belonging to the institution), Monika KRATOCHVÍLOVÁ (203 Czech Republic, belonging to the institution), Hana POLANSKÁ (203 Czech Republic, belonging to the institution), Zuzana HORÁKOVÁ (203 Czech Republic), Rom KOSTŘICA (203 Czech Republic), Petr BABULA (203 Czech Republic, belonging to the institution), Z. HEGER (203 Czech Republic) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution).
Edition Oncotarget, Albany, Impact Journals, 2017, 1949-2553.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.168 in 2016
RIV identification code RIV/00216224:14110/17:00095052
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.18632/oncotarget.19914
UT WoS 000410291200128
Keywords in English head and neck neoplasms; coculture techniques; cell line; tumor; carcinoma
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 12:43.
Abstract
In this study, we describe the establishment of the human papillomavirus 18-positive, stage II, grade 1, T2N0M0 head and neck tumor primary cell line derived from oral squamous cell carcinoma of a non-smoking patient by using two different protocols. Furthermore, a preparation of subpopulations derived from this primary cell line according to the cluster of differentiation molecules CD44/CD90 status using magnetic bead-based separation and their characterization was performed. Impedance-based real-time cell analysis, enzyme-linked immunsorbant assay (ELISA), wound-healing assay, flow-cytometry, gene expression analysis, and MTT assay were used to characterize these four subpopulations (CD44(+)/CD90(-), CD44(-)/CD90(-), CD44(+)/CD90(+), CD44(-)/CD90(-)). We optimised methodics for establishement of primary cell lines derived from oral squamous cell carcinoma tissue samples and subsequent separation of mesenchymal (CD90(+)) and epithelial (CD90(-)) types of tumorous cells. Primary cell line prepared by using trypsin proteolysis was more viable than the one prepared by using collagenase. According to our results, CD90 separation is a necessary step in preparation of permanent tumor-tissue derived cell lines. Based on the wound-healing assay, CD44(+) cells exhibited stronger migratory capacity than CD44(-) subpopulations. CD44(+) subpopulations had also significantly higher expression of BIRC5 and SOX2, lower expression of FLT1 and IL6, and higher levels of basal autophagy compared to CD44(-) subpopulations. Furthermore, co-cultivation experiments revealed that CD44(-)/CD90(+) cells supported growth of epithelial tumor cells (CD44(+)/CD90(-)). On the contrary, factors released by CD44(+)/CD90(+) type of cells seem to have rather inhibiting effect. The most cisplatin-resistant subpopulation with the shortest doubling time was CD44(-)/CD90(+), but this subpopulation had a low migratory capacity.
Links
GA16-12454S, research and development projectName: Charakterizace a modifikace komplexní odpovědi buněk nádorů hlavy a krku na různá záření - krok kupředu ke kombinované personalizované (radio)terapii
Investor: Czech Science Foundation
NV16-29835A, research and development projectName: Molekulárně-genetické markery predikce účinnosti radioterapie u nádorů hlavy a krku
ROZV/24/LF/2016, interní kód MUName: LF - Příspěvek IP 2016
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 25/4/2024 14:24